Bloomberg Businessweek

U.S. Calls for Pause of J&J Shot on Clots

Informações:

Sinopse

Bloomberg News U.S. Healthcare Reporter Riley Griffin and Dr. Mario Ramirez, Managing Director at Opportunity Labs, discuss U.S. health officials probing a rare blood-clot complication tied to Johnson & Johnson’s Covid-19 vaccine. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Finance Reporter Noah Buhayar talk about how one section of Seattle is bouncing back from the pandemic. Bloomberg News Reporter Akayla Gardner explains how Black Americans are embracing stocks and Bitcoin as a way to build wealth. And we Drive to the Close with David Marcus, CEO at Evermore Global Advisors. Hosts: Carol Massar. Producer: Paul Brennan.